Rahul Khurana from Northern California Retina Vitreous Associates: Using Aflibercept to Extend Treatment of Central Retinal Vein Occlusions

Patients diagnosed with central retinal vein occlusions may not like having intravitreal injections but research is being done to see if the frequency of the injections can be reduced over time.

At the annual meeting of the American Society of Retina Specialists in San Francisco Rahul Khurana, MD, from Northern California Retina Vitreous Associates discussed the results of the NEWTON Study. The goal of the study was to see whether patients receiving Aflibercept could go longer between injections while still having the same visual results in between. Khurana said that while there is no cure for patients witht he condition now this is at least a positive step for treatment for patients.